• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外实验中(以 SARS-CoV-2 疫苗抗原为例)修饰的细胞因子和 VEGFA 基因表达的特征。

Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen).

机构信息

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Perm, Russia.

出版信息

Bull Exp Biol Med. 2024 Jan;176(3):354-358. doi: 10.1007/s10517-024-06023-0. Epub 2024 Feb 12.

DOI:10.1007/s10517-024-06023-0
PMID:38342808
Abstract

The influence of SARS-CoV-2 antigen on the cytokine-producing function of immune cells was studied. We observed suppression of the production of proinflammatory cytokines by 11-46% relative to the spontaneous level under the influence of SARS-CoV-2 antigen vaccine simulator, as well as when it was co-administered with cortisol (IL-6 by 1.8 times and IFNγ by 1.57 times) compared with control samples. IL-8 production was reduced by 1.72 times relative to its spontaneous level. IL-8 production was reduced by 1.72 times relative to its spontaneous level. Under conditions of SARS-CoV-2 stimulation with the vaccine antigen in vitro, an increase in the relative scaled expression of the VEGFA gene by 2.16 times relative to the spontaneous level was observed, which can be regarded as a model "cytokine storm" scenario. The obtained experimental data verify the ideas about the pathogenetic mechanisms of the COVID-19 and can contribute to the development of new approaches to the correction of its complications.

摘要

研究了 SARS-CoV-2 抗原对免疫细胞产生细胞因子功能的影响。我们观察到,在 SARS-CoV-2 抗原疫苗模拟器的影响下,与对照样本相比,细胞因子的产生被抑制了 11-46%,相对于自发水平;当与皮质醇(IL-6 增加 1.8 倍,IFNγ 增加 1.57 倍)同时给药时也是如此。与自发水平相比,IL-8 的产生减少了 1.72 倍。在体外用疫苗抗原刺激 SARS-CoV-2 的情况下,与自发水平相比,VEGFA 基因的相对标度表达增加了 2.16 倍,可以将其视为一种“细胞因子风暴”的模型场景。所获得的实验数据验证了关于 COVID-19 发病机制的想法,并有助于开发纠正其并发症的新方法。

相似文献

1
Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen).在体外实验中(以 SARS-CoV-2 疫苗抗原为例)修饰的细胞因子和 VEGFA 基因表达的特征。
Bull Exp Biol Med. 2024 Jan;176(3):354-358. doi: 10.1007/s10517-024-06023-0. Epub 2024 Feb 12.
2
COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control.COVID-19 灭活和非复制型病毒载体疫苗在表观遗传控制下诱导人类单核细胞中调节训练表型。
Front Cell Infect Microbiol. 2023 Jul 14;13:1200789. doi: 10.3389/fcimb.2023.1200789. eCollection 2023.
3
Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice.黏膜免疫接种表达 SARS-CoV-2 表位的植物乳杆菌可在小鼠体内诱导体液和黏膜免疫应答。
Microb Cell Fact. 2023 May 9;22(1):96. doi: 10.1186/s12934-023-02100-7.
4
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.环孢素 A 通过三种 SARS-CoV-2 变体抑制肺细胞中的病毒感染和释放以及细胞因子产生。
Microbiol Spectr. 2022 Feb 23;10(1):e0150421. doi: 10.1128/spectrum.01504-21. Epub 2022 Jan 5.
5
Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.单细胞转录组图谱揭示 COVID-19 疫苗接种和自然 SARS-CoV-2 感染之间的独特免疫反应。
J Med Virol. 2022 Nov;94(11):5304-5324. doi: 10.1002/jmv.28012. Epub 2022 Jul 30.
6
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.SARS-CoV-2 将不断扫荡其踪迹:一种含有 CpG 基序的“套索”疫苗,针对多面病毒。
Inflamm Res. 2020 Sep;69(9):801-812. doi: 10.1007/s00011-020-01377-3. Epub 2020 Jul 12.
7
The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus.佐剂类型对 RBD/N 鸡尾酒抗原作为 SARS-CoV-2 病毒疫苗候选物的免疫原性的影响。
Microbiol Spectr. 2023 Jun 15;11(3):e0256422. doi: 10.1128/spectrum.02564-22. Epub 2023 May 18.
8
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.宿主对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的保护性免疫与 COVID-19 疫苗诱导的对 SARS-CoV-2 及其变体的免疫。
Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541.
9
Immune response scenario and vaccine development for SARS-CoV-2 infection.针对 SARS-CoV-2 感染的免疫反应场景和疫苗开发。
Int Immunopharmacol. 2021 May;94:107439. doi: 10.1016/j.intimp.2021.107439. Epub 2021 Jan 29.
10
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.

本文引用的文献

1
Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation.COVID-19 患者外周血细胞在非特异性体外刺激后的细胞因子产生能力。
Inflamm Res. 2022 Mar;71(3):331-341. doi: 10.1007/s00011-022-01543-9. Epub 2022 Feb 14.
2
Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients.抗血管内皮生长因子药物:在危重症 COVID-19 患者的治疗中作为有吸引力的靶点。
Int Immunopharmacol. 2021 Dec;101(Pt B):108257. doi: 10.1016/j.intimp.2021.108257. Epub 2021 Oct 16.
3
The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review.
SARS-CoV-2 与血管生成之间被误解的联系。一篇叙述性评论。
Pulmonology. 2023 Jul-Aug;29(4):323-331. doi: 10.1016/j.pulmoe.2021.08.004. Epub 2021 Aug 27.
4
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.新型冠状病毒肺炎中的内皮细胞激活与功能障碍:从基本机制到潜在治疗方法
Signal Transduct Target Ther. 2020 Dec 24;5(1):293. doi: 10.1038/s41392-020-00454-7.
5
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.COVID-19 中的血管内皮功能障碍:当前研究结果及治疗意义。
Atherosclerosis. 2020 Dec;314:58-62. doi: 10.1016/j.atherosclerosis.2020.10.014. Epub 2020 Oct 14.
6
Cytokine profile and disease severity in patients with COVID-19.COVID-19 患者的细胞因子谱与疾病严重程度。
Cytokine. 2021 Jan;137:155323. doi: 10.1016/j.cyto.2020.155323. Epub 2020 Sep 30.
7
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.严重的免疫抑制,而非细胞因子风暴,是 COVID-19 感染的特征。
JCI Insight. 2020 Sep 3;5(17):140329. doi: 10.1172/jci.insight.140329.
8
The cytokine storm and COVID-19.细胞因子风暴与 COVID-19。
J Med Virol. 2021 Jan;93(1):250-256. doi: 10.1002/jmv.26232. Epub 2020 Sep 30.
9
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.严重急性呼吸综合征冠状病毒 2 感染:细胞因子在 COVID-19 疾病中的作用。
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
10
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.